Biomarker study for bile duct and gallbladder cancer
Part of Cancer, Digestive system clinical trials.
This study looks at tumor tissue samples from people with bile duct or gallbladder cancer to find biomarkers (clues in the tumor) that might help guide future treatment. By studying these samples, researchers hope to understand more about these cancers and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of bile duct cancer or gallbladder cancer (any stage).
- Your diagnosis must have been made within the last 15 years.
- You must have a stored tumor sample (from a biopsy or surgery) that can be tested.
- Your basic medical and survival information must be available in your records.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is collecting information and blood samples from people with biliary tract cancer to understand how certain markers and quality-of-life measures relate to treatment outcomes. The findings may help improve future care and support.
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
This study looks at whether a bile sample and a blood sample can show the same gene changes found in a tumor biopsy for people with bile duct or gallbladder cancer. It aims to see if these simpler tests could be used instead of a tumor tissue sample.
This study looks for new ways to measure cancer-related “biomarkers” (signals in blood or tumor samples) in people with bile duct cancer or gallbladder cancer. The goal is to improve how these cancers are identified and tracked, which could help doctors make better treatment decisions.
This study looks at lab markers (including genetic tests) to predict how people with bile duct cancer respond to treatment. Your answers and samples may help doctors personalize care for bile duct cancer in the future.
This study is collecting medical information and blood samples from people with bile duct or gallbladder tumors to build a database that can help doctors better understand these conditions and improve future treatments.
Hear when a new Biliary Tract Cancer (BTC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.